XSTO
PRO
Market cap36mUSD
May 30, Last price
18.95SEK
1D
5.57%
1Q
-32.32%
IPO
16.98%
Name
Promimic AB
Chart & Performance
Profile
Promimic AB (publ) manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets. It offers HAnano surface technology that combines various properties that are known to improve osseointegration into one unique surface modification. The company was incorporated in 2004 and is headquartered in Mölndal, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
Income | |||||||
Revenues | 43,976 18.63% | 37,070 128.63% | 16,214 100.99% | ||||
Cost of revenue | (4,009) | 696 | 390 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 47,985 | 36,374 | 15,824 | ||||
NOPBT Margin | 109.12% | 98.12% | 97.59% | ||||
Operating Taxes | 5,438 | 1,404 | 499 | ||||
Tax Rate | 11.33% | 3.86% | 3.15% | ||||
NOPAT | 42,547 | 34,970 | 15,325 | ||||
Net income | (12,550) 36.09% | (9,222) -41.95% | (15,887) 4.61% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 4,935 | 80,099 | |||||
BB yield | -0.82% | -43.70% | |||||
Debt | |||||||
Debt current | (5,605) | ||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | 1,243 | ||||||
Net debt | (35,765) | (50,323) | (60,405) | ||||
Cash flow | |||||||
Cash from operating activities | (10,363) | (3,750) | (12,262) | ||||
CAPEX | (5,788) | (10,534) | |||||
Cash from investing activities | (9,991) | (9,365) | (10,534) | ||||
Cash from financing activities | 5,184 | 4,935 | 72,160 | ||||
FCF | 35,940 | 30,018 | 15,440 | ||||
Balance | |||||||
Cash | 35,765 | 50,323 | 58,800 | ||||
Long term investments | (4,000) | ||||||
Excess cash | 33,566 | 48,470 | 53,989 | ||||
Stockholders' equity | 1,889 | (122,803) | (113,053) | ||||
Invested Capital | 68,025 | 199,522 | 188,300 | ||||
ROIC | 31.81% | 18.03% | 9.85% | ||||
ROCE | 68.63% | 47.41% | 21.03% | ||||
EV | |||||||
Common stock shares outstanding | 18,910 | 18,481 | 15,801 | ||||
Price | 22.50 -31.19% | 32.70 181.90% | 11.60 | ||||
Market cap | 425,485 -29.59% | 604,331 229.71% | 183,290 | ||||
EV | 389,720 | 554,008 | 122,885 | ||||
EBITDA | 47,985 | 40,492 | 18,433 | ||||
EV/EBITDA | 8.12 | 13.68 | 6.67 | ||||
Interest | 92 | 166 | |||||
Interest/NOPBT | 0.25% | 1.05% |